Please select the eligibility criteria that correspond to the clinical trial below.
Title: Tele Follow-up Using Patient-reported Outcomes (PRO) Measures in Patients With Chronic Kidney Disease - the PROKID Study
Brief Summary: This randomized controlled trial (RCT) will evaluate if PRO-based follow-up is at least as effective as usual outpatient follow-up in managing decline in renal function and maintaining patients' quality of life. Furthermore, we intend to characterize the target patient group that is suitable for PRO-based follow up in a group of patients suffering from renal insufficiency.


Options:
A: Inclusion Criteria:

* Employed women and men, aged 18 - 64 years
* Seeking care for:
* depression
* anxiety
* musculoskeletal disorders
* gastrointestinal and cardio-vascular symptoms
* other stress-related symptoms

Exclusion Criteria:

* Currently on sick-leave or have been on sick-leave with doctor's certificate the last month
* Have been absent from work due to illness more than 7 days the last month (without doctor's certificate)
* On sickness or activity payments
* Pregnant women
* Patients seeking care for:
* allergy
* diabetes
* urinary tract infection
* infections (whooping cough, tonsillitis)
* COPD
* fractures
* lumps and spots
* psychiatric diagnoses such as schizophrenia, other psychoses or bipolar diagnoses
* prolonging of sick-leave certificate
* check up of chronic disease
B: Inclusion Criteria:

* General hospital inpatients with risky drinking (AUDIT-C \>= 4/5 (women/men) and AUDIT \< 20)

Exclusion Criteria:

* Patients already recruited during an earlier hospital stay
* Patients physically and mentally not capable of participating in the study
* Patients with a hospital stay of less than 24 hours
* Patients with insufficient language/ reading skills
* Patients employed at one of the departments participating in the study or conducting the study
* Patients with more severe alcohol problems (AUDIT \>= 20)
C: Inclusion Criteria:

Patients

* Adults ≥ 18 years of age,
* Receiving care from a participating primary care physician
* Report a moderate level of severity ( ≥ 4 on a 0 to 10 scale) on at least one of 5 symptoms (sleep, pain, anxiety, depression, energy/fatigue) based on a 5-item screener.

Physicians

* Primary care physicians within the Indiana University Health and Eskenazi Health systems

Exclusion Criteria:

Patients

* Patients less than 18 years of age
* Patients who do not receive care from a participating primary care physician
* Patients who have less than a moderate level of severity (less than 4 on a 0 to 10 item scale) on each of the 5 symptoms (sleep, pain, anxiety, depression, energy/fatigue) based on a 5-item screener.

Physicians:

* Primary care physicians who do not practice within the Indiana University Health or Eskenazi Health systems
D: Inclusion Criteria:

* Referred to the renal care services at Aarhus University Hospital or Regional Hospital Central Jutland, Viborg
* Estimated Glomerular Filtration Rate (eGFR) between 10-39 mL/min 1.73m2.
* Aged ≥18 years old
* Ability to provide fully informed written consent for participation in the study

Exclusion Criteria:

* Patients unwilling to participate in PRO-based follow-up
* Patients who, in the opinion of the consenting professional, cannot speak, read or write Danish sufficiently well to complete the PRO questionnaire unaided
* Patients with hearing disabilities
* Patients with an eGFR \> 39mL/min 1.73m2 at their first visit at the hospital
* Patients who have received (or have a scheduled date to receive) a kidney transplant
* A terminal illness that, in the opinion of the consultant assessing eligibility, is likely to lead to the death of the patient within 6 months of starting participation in the study
* Patients receiving chemotherapy, with end stage Chronic Obstructive Lung disease, or with heart failure with Ejection Fraction (EF)\< 15 %.
* A projected risk of progression to end-stage renal failure within 6 months, determined from albumin/creatinine ratio

Answer: D